Real-time enrollment status for this relapsed or refractory lymphomas clinical trial
Current Status
Recruiting
Checked: July 14, 2026 at 12:12 AM UTC
| NCT Number | NCT06132503 |
| Recruiting Status | Recruiting |
| Condition | Relapsed or Refractory Lymphomas |
| Phase | Clinical Trial |
| Target Enrollment | 110 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Lantern Pharma Inc. |
| Last Updated on CT.gov | May 4, 2026 (May 4, 2026) |
As of July 14, 2026: Clinical trial NCT06132503 is currently recruiting participants. This clinical trial study for relapsed or refractory lymphomas is actively seeking new participants at 1 location across the United States. The study is sponsored by Lantern Pharma Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06132503 is actively recruiting participants as of July 14, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06132503 was last updated May 4, 2026 (May 4, 2026). HelloStudys verifies this status automatically.